 MedPage Today | Everolimus DES: Stent-thrombosis advantage vs bare-metal stents in meta-analysis TheHeart.Org London, UK - Drug-eluting stents (DES) should have a stent-thrombosis risk as low as possible, and compared with other types, cobalt-chromium everolimus-eluting stents (CoCr-EES) could have it down to a Xience [1]. A new meta-analysis has suggested ... Thrombosis Risk Lower with Xience Stent Drug-Eluting Stents Reduce Risk of Thrombosis Large Meta-Analysis Finds Very Low Thrombosis Rates for Xience Stent |
